Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
- PMID: 3569757
- DOI: 10.1016/0016-5085(87)90613-5
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
Abstract
Five hundred twelve (373 men, 139 women) patients, aged 1-75 yr, with chronic hepatitis B virus infection seen during a 5-yr period were analyzed. Of these, 43.8% were hepatitis B e antigen (HBeAg)-positive, 49.2% were positive for hepatitis B e antibody, and 7% were negative for both HBeAg and hepatitis B e antibody at presentation. The cumulative probability of clearing HBeAg at the end of the first, second, and third years was 17%, 30%, and 34%, respectively. The probability of clearing HBeAg increased with the age of the patients. Reversion to HBeAg occurred in 7.8% of patients who were HBeAg-negative at presentation and 32.3% of HBeAg-positive patients who cleared HBeAg. In 70.6% of these patients, serum hepatitis B virus-deoxyribonucleic acid was persistently positive or became detectable at the time of HBeAg reversion. Most reversions occurred during the "e-window" phase. The reversions were transient in 31.8% of the cases. Recognition of the dynamics of these serologic changes is important in the evaluation of therapeutic regimens aimed at suppression of HBV replication and call for controlled trials with adequate duration of follow-up. Biochemical exacerbation of liver disease accompanied 38.7% of HBeAg to hepatitis B e antibody seroconversions and 34.8% of reversions. Such exacerbations may be mistaken for acute attacks of hepatitis B in patients not previously recognized to be hepatitis B surface antigen carriers and, in the absence of serial serologic data, are indistinguishable from superimposed non-A, non-B hepatitis.
Similar articles
-
Chronic hepatitis B infection in Singapore.Singapore Med J. 1991 Oct;32(5):352-5. Singapore Med J. 1991. PMID: 1793464
-
Hepatitis B virus DNA in hepatitis B surface antigen-positive blood donors: relation to the hepatitis B e system and outcome in recipients.J Infect Dis. 1986 Feb;153(2):298-303. doi: 10.1093/infdis/153.2.298. J Infect Dis. 1986. PMID: 3944482
-
Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.Biken J. 1984 Dec;27(4):169-76. Biken J. 1984. PMID: 6100353
-
Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.Am J Gastroenterol. 1986 Apr;81(4):239-45. Am J Gastroenterol. 1986. PMID: 3962948
-
Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.J Med Virol. 2004 Mar;72(3):363-9. doi: 10.1002/jmv.10534. J Med Virol. 2004. PMID: 14748059
Cited by
-
Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion.PLoS One. 2015 Feb 17;10(2):e0117590. doi: 10.1371/journal.pone.0117590. eCollection 2015. PLoS One. 2015. PMID: 25689069 Free PMC article.
-
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Hepatol Int. 2016 Jan;10(1):1-98. doi: 10.1007/s12072-015-9675-4. Epub 2015 Nov 13. Hepatol Int. 2016. PMID: 26563120 Free PMC article.
-
Natural history of chronic hepatitis B: phases in a complex relationship.World J Gastroenterol. 2014 Aug 14;20(30):10395-404. doi: 10.3748/wjg.v20.i30.10395. World J Gastroenterol. 2014. PMID: 25132755 Free PMC article. Review.
-
Natural history of chronic hepatitis B virus infection.Med Microbiol Immunol. 2015 Feb;204(1):5-10. doi: 10.1007/s00430-014-0369-7. Epub 2014 Dec 25. Med Microbiol Immunol. 2015. PMID: 25540037 Review.
-
Hepatitis B reactivation and rituximab in the oncology practice.Oncologist. 2010;15(10):1113-21. doi: 10.1634/theoncologist.2010-0106. Epub 2010 Oct 7. Oncologist. 2010. PMID: 20930099 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous